We are live on ! Find out more
UROV

Urovant Sciences Ltd.
UROV

Delisted

UROV was delisted on the 26th of March, 2021.

Back to rankings

27 hedge funds and large institutions have $64.3M invested in Urovant Sciences Ltd. in 2019 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 2 increasing their positions, 8 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

267% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 3

42% more funds holding

Funds holding: 19 → 27 (+8)

16% more capital invested

Capital invested by funds: $55.3M → $64.3M (+$9M)

75% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 8

Holders
27
Holders Change
+8
Holders Change %
+42.11%
% of All Funds
0.59%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
2
Reduced
8
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
PA
Perceptive Advisors
New York
+$3.22M
2
WCM
Wildcat Capital Management
New York
+$1.91M
3
Point72 Asset Management
Point72 Asset Management
Connecticut
+$434K
4
LA
LVW Advisors
New York
+$341K
5
Goldman Sachs
Goldman Sachs
New York
+$157K

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$3.47M
2
EAM
Eventide Asset Management
Massachusetts
-$3.18M
3
PM
Prosight Management
Texas
-$347K
4
SCM
Sio Capital Management
New York
-$271K
5
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$217K
Name Holding Trade Value Shares
Change 		Change in
Stake
PA
1
Perceptive Advisors
New York
$21.3M +$3.22M +371,121 +20%
Fidelity Investments
2
Fidelity Investments
Massachusetts
$16.2M – – –
Adage Capital Partners
3
Adage Capital Partners
Massachusetts
$9.23M -$217K -25,000 -3%
PWAM
4
Park West Asset Management
California
$4.1M – – –
BlackRock
5
BlackRock
New York
$2.7M +$17.9K +2,065 +0.7%
WCM
6
Wildcat Capital Management
New York
$2.08M +$1.91M +219,975 New
SCM
7
Sio Capital Management
New York
$1.79M -$271K -31,200 -14%
SB
8
Samsara BioCapital
California
$1.49M – – –
Vanguard Group
9
Vanguard Group
Pennsylvania
$1.25M – – –
PM
10
Prosight Management
Texas
$972K -$347K -39,963 -28%
Geode Capital Management
11
Geode Capital Management
Massachusetts
$795K -$8.97K -1,034 -1%
KCM
12
Kornitzer Capital Management
Kansas
$484K – – –
Point72 Asset Management
13
Point72 Asset Management
Connecticut
$474K +$434K +50,000 New
Millennium Management
14
Millennium Management
New York
$372K -$3.47M -399,526 -91%
LA
15
LVW Advisors
New York
$372K +$341K +39,312 New
Goldman Sachs
16
Goldman Sachs
New York
$172K +$157K +18,140 New
First Trust Advisors
17
First Trust Advisors
Illinois
$163K +$149K +17,207 New
WMSA
18
Weiss Multi-Strategy Advisers
New York
$145K -$83.8K -9,665 -39%
Northern Trust
19
Northern Trust
Illinois
$131K -$28.9K -3,331 -19%
UBS Group
20
UBS Group
Switzerland
$30K +$27.2K +3,138 New
MWNA
21
Marshall Wace North America
New York
$24K +$22.3K +2,567 New
Bank of America
22
Bank of America
North Carolina
$14K +$12.7K +1,463 New
CSS
23
Cubist Systematic Strategies
Connecticut
$12K +$10.7K +1,239 New
Victory Capital Management
24
Victory Capital Management
Texas
$10K +$9K +1,037 New
Royal Bank of Canada
25
Royal Bank of Canada
Ontario, Canada
$3K – – –
1
2

UROV Hedge Fund Activity: Q3 2019 in Review

27 of the 4,561 institutional investors tracked by Wall St. Rank reported a position in Urovant Sciences Ltd. (UROV) for Q3 2019, worth a combined $64.3M — up 16% from $55.3M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new UROV positions and 3 closed out — a net gain of 8 holders — while 2 added to existing stakes and 8 trimmed.

The largest buyer was Perceptive Advisors, adding an estimated $3.22M. The largest seller was Millennium Management, cutting an estimated $3.47M.

  • 27 institutional investors held Urovant Sciences Ltd. (UROV) as of Q3 2019, up from 19 in Q2 2019.
  • Funds reported $64.3M of Urovant Sciences Ltd. stock for Q3 2019, up 16% quarter-over-quarter.
  • 11 funds opened new Urovant Sciences Ltd. positions in Q3 2019 and 3 closed out, a net change of +8 holders.
  • The largest Urovant Sciences Ltd. buyer in Q3 2019 was Perceptive Advisors, an estimated $3.22M added.
  • The largest Urovant Sciences Ltd. seller in Q3 2019 was Millennium Management, an estimated $3.47M sold.

Based on aggregated 13F filings for Q3 2019.